Press Release: April 10, 2020
Coimbatore, India, April 10 — With the extreme thirst of the world focussed on ICU Oxygen Ventilators (which are life savers in COVID 19 disaster), world demand for those overshoots production by 500% to 1000%. Student startup JK Data Systems Incubated in AIC Raise, Supported by Atal Innovation Mission, NITI Aayog, Govt of India and students of Rathinam Group of Institutions, Coimbatore has prototyped a ventilator with all electronic features for just less than Rs. 25000.
The student startup company of Mr. Karthik S, Mr. Gowtham S , Ebin Ephrem Elavathingal, Senior Manager at AIC Raise and team along with support of Bio-Medical and Computer Science department of Rathinam College has built this product which has the potential of solving the huge demand for these in India and abroad. This ventilator is made with an re-engineered design of an international open source ventilator project. The students started this project by March 22 and came up with the prototype in 4 days. This Intermittent Positive Pressure Breathing ventilator ( IPPV) is now ready for testing.
This device consists of monitoring and control of the tidal volume, breath per minute, inspiration expiration ratio adjustments. It is also enhanced with pressure, flow and oxygen monitoring systems. Since the device is made with optimal design and features to control its operations, the team hopes that the ventilator will help many patients in our nation. After the testing, the device will seek license from Governments for production in volumes.
Ebin Ephrem Elavathingal, Senior Manager at the AIC Raise, says that . who was the advisor to the startup who did the ventilator. If we want to make the device as an automated IPPV which can be used in pandemic emergency. The current prototype is very near to the medical usage. But we are trying to make it as better as we can use in the pandemic crisis. The team’s 25000INR design, which they plan to make open-source to encourage others to duplicate it, is ready for testing on COVID-19 patients once it clears legal review, its designers say.